OPNT - Opiant Pharmaceuticals' (OPNT) CEO Roger Crystal on Q1 2020 Results - Earnings Call Transcript
Opiant Pharmaceuticals, Inc. (OPNT)
Q1 2020 Earnings Conference Call
May 12, 2020 4:30 PM ET
Company Participants
Ben Atkins – Vice President of Communication and Investor Relations
Roger Crystal – President and Chief Executive Officer
David O’Toole – Chief Financial Officer
Conference Call Participants
Brandon Folkes – Cantor Fitzgerald
Boris Peaker – Cowen and Company
Carl Byrnes – Northland Securities
David Belt – Zacks Investment Research
Presentation
Operator
Greetings, and welcome to the Opiant Pharmaceuticals First Quarter 2020 Earnings Conference Call. [Operator Instructions] As a reminder this conference is being recorded.
I will now like